NCT05828836View on ClinicalTrials.gov

Allopurinol and Quality of Life in Liver Cirrhosis

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

January 15, 2023

Study Completion Date

March 1, 2023

Conditions

Cirrhosis, Liver

Interventions

DRUG

Allopurinol Tablet

allopurinol300mg once daily

DRUG

Placebo

placebo once daily

Trial Locations (1)

31679

Faculty of Pharmacy, Tanta

All Listed Sponsors

lead

Tanta University

OTHER